Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 See also  





2 References  














4'Cl-CUMYL-PINACA







Add links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 

(Redirected from 4'F-CUMYL-5F-PINACA)

4'Cl-CUMYL-PINACA
Legal status
Legal status
  • DE: NpSG (Industrial and scientific use only)
  • UK: Class B
  • Identifiers
    • N-[2-(4-chlorophenyl)propan-2-yl]-1-pentylindazole-3-carboxamide

    CAS Number
    PubChem CID
    ChemSpider
    CompTox Dashboard (EPA)
    Chemical and physical data
    FormulaC22H26ClN3O
    Molar mass383.92 g·mol−1
    3D model (JSmol)
    • CCCCCN1C2=CC=CC=C2C(=N1)C(=O)NC(C)(C)C3=CC=C(C=C3)Cl

    • InChI=1S/C22H26ClN3O/c1-4-5-8-15-26-19-10-7-6-9-18(19)20(25-26)21(27)24-22(2,3)16-11-13-17(23)14-12-16/h6-7,9-14H,4-5,8,15H2,1-3H3,(H,24,27)

    • Key:APEGZJKYOJZGKH-UHFFFAOYSA-N

    4'Cl-CUMYL-PINACA (also known as SGT-157) is an indazole-3-carboxamide based synthetic cannabinoid compound, first disclosed in a 2014 patent.[1] It has been sold as a designer drug, first reported in 2020 alongside two similar compounds 4'F-CUMYL-5F-PICA (SGT-64) and 4'F-CUMYL-5F-PINACA (SGT-65),[2] and the metabolism of these compounds has been studied to assist with their identification in forensic casework.[3]

    4'F-CUMYL-5F-PICA (SGT-64), CAS# 1631074-52-6 [1]
    4'F-CUMYL-5F-PINACA (SGT-65), CAS# 1631074-53-7 [2]

    See also[edit]

    References[edit]

    1. ^ WO 2014167530, Bowden MJ, Williamson JP, "Cannabinoid compounds", published 16 October 2014. 
  • ^ Zangani C, Schifano F, Napoletano F, Arillotta D, Gilgar L, Guirguis A, et al. (2020). "The e-Psychonauts' 'Spiced' World; Assessment of the Synthetic Cannabinoids' Information Available Online". Current Neuropharmacology. 18 (10): 966–1051. doi:10.2174/1570159X18666200302125146. PMC 7709145. PMID 32116194.
  • ^ Stalberga D, Ingvarsson S, Bessa G, Maas L, Vikingsson S, Persson M, et al. (December 2022). "Metabolism studies of 4'Cl-CUMYL-PINACA, 4'F-CUMYL-5F-PINACA and 4'F-CUMYL-5F-PICA using human hepatocytes and LC-QTOF-MS analysis" (PDF). Basic & Clinical Pharmacology & Toxicology. 132 (3): 263–280. doi:10.1111/bcpt.13829. PMID 36544361. S2CID 255039508.

  • t
  • e

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=4%27Cl-CUMYL-PINACA&oldid=1205097680"

    Categories: 
    Cannabinoids
    Designer drugs
    Indazolecarboxamides
    Chloroarenes
    Cannabinoid stubs
    Hidden categories: 
    Articles with short description
    Short description matches Wikidata
    Articles without EBI source
    Chemical pages without DrugBank identifier
    Articles without KEGG source
    Articles without UNII source
    Drugs missing an ATC code
    Articles containing unverified chemical infoboxes
    All stub articles
     



    This page was last edited on 8 February 2024, at 21:27 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki